The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun.
trd
First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant Depression
Beckley Psytech’s Phase IIa study will explore the safety, efficacy and pharmacokinetics of a single dose of BPL-003, in combination with psychological support, in patients with Treatment Resistant Depression (TRD).
Shrooms vs. LSD: Differences, Similarities & Research Progress
A direct comparison between the subjective effects, onset time, mystical experience and research of shrooms vs. LSD.
End of content
End of content